• 2024
  Boullé M, Leleu A, Schacre S, Banal C, Boucharlat A, Renault S, Hollenstein M, Frosk P, Yates F, Lefort N, Agou F, Generation of IPi002-A/B/C human induced pluripotent stem cell lines from MARCH amniotic fluid cells., Stem Cell Res 2024 Oct; 81(): 103589.
• 2024
  Khan S, Partuk EO, Chiaravalli J, Kozer N, Shurrush KA, Elbaz-Alon Y, Scher N, Giraud E, Tran-Rajau J, Agou F, Barr HM, Avinoam O, High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors., iScience 2024 Jun; 27(6): 110019.
• 2024
  Boullé M, Boucharlat A, Leleu A, Banal C, Coussement A, Hollenstein M, Yates F, Lefort N, Agou F, Generation of IPi001-A/B/C human induced pluripotent stem cell lines from healthy amniotic fluid cells., Stem Cell Res 2024 Apr; 76(): 103350.
• 2024
  Martinez FJ, White M, Guillotte-Blisnick M, Huon C, Boucharlat A, Agou F, England P, Popovici J, Hou MM, Silk SE, Barrett JR, Nielsen CM, Reimer JM, Mukherjee P, Chauhan VS, Minassian AM, Draper SJ, Chitnis CE, PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial., NPJ Vaccines 2024 Jan; 9(1): 10.
• 2023
  Touret F, Giraud E, Bourret J, Donati F, Tran-Rajau J, Chiaravalli J, Lemoine F, Agou F, Simon-Lorière E, van der Werf S, de Lamballerie X, Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
• 2023
  Hassan H, Chiavaralli J, Hassan A, Bedda L, Krischuns T, Chen KY, Li ASM, Delpal A, Decroly E, Vedadi M, Naffakh N, Agou F, Mallart S, Arafa RK, Arimondo PB, , Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors., RSC Med Chem 2023 Mar; 14(3): 507-519.
• 2022
  Mikaël Boullé,* Laurianne Davignon, Keïs Nabhane Saïd Halidi, Salomé Guez, Emilie Giraud, Marcel Hollenstein, and Fabrice Agou*, High-Content RNAi Phenotypic Screening Unveils the Involvement of Human Ubiquitin-Related Enzymes in Late Cytokinesis, Cells 2022, 11(23), 3862.
• 2022
  Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, , , Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H, Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
• 2022
  Chen KY, Krischuns T, Varga LO, Harigua-Souiai E, Paisant S, Zettor A, Chiaravalli J, Delpal A, Courtney D, O'Brien A, Baker SC, Decroly E, Isel C, Agou F, Jacob Y, Blondel A, Naffakh N, , A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors., Antiviral Res 2022 May; 201(): 105272.
• 2021
  Anca F. Savulescu, Robyn Brackin, Emmanuel Bouilhol, Benjamin Dartigues, Jonathan H. Warrell, Mafalda R. Pimentel, Nicolas Beaume, Isabela C. Fortunato, Stephane Dallongeville, Mikaël Boullé, Hayssam Soueidan, Fabrice Agou, Jan Schmoranzer, Jean-Christophe Olivo-Marin, Claudio A. Franco, Edgar R. Gomes, Macha Nikolski, and Musa M. Mhlanga , Interrogating RNA and protein spatial subcellular distribution in smFISH data with DypFISH, Volume 1, Issue 5, 27 September 2021, 100068.
• 2021
  Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, Grauslys A, Walter M, Agou F, Chakrabarti LA, Craik CS, Eyers CE, Eyers PA, Gambin Y, Jones AR, Sierecki E, Verdin E, Vignuzzi M, Emmott E, , Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential., Nat Commun 2021 09; 12(1): 5553.
• 2019
  Karine Nozeret, Alix Boucharlat, Fabrice Agou, Nienke Buddelmeijer, A sensitive fluorescence-based assay to monitor enzymatic activity of the essential integral membrane protein Apolipoprotein N-acyltransferase (Lnt), Scientific Reports, 2019, 9 (1), pp.15978. ⟨10.1038/s41598-019-52106-8⟩.
• 2019
  Said Halidi KN, Fontan E, Boucharlat A, Davignon L, Charpentier M, Boullé M, Weil R, Israël A, Laplantine E, Agou F., Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis., iScience. 2019 Sep 25;20:292-309.
• 2017
  Bal E, Laplantine E, Hamel Y, Dubosclard V, Boisson B, Pescatore A, Picard C, Hadj-Rabia S, Royer G, Steffann J, Bonnefont JP, Ursini VM, Vabres P, Munnich A, Casanova JL, Bodemer C, Weil R, Agou F, Smahi A, Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti., J Allergy Clin Immunol. 2017 Dec;140(6):1671-1682.e2.
• 2016
  Janine Scholefield, Ricardo Henriques, Anca Savulescu, Elisabeth Fontan, Alix F Boucharlat, Emmanuel Laplantine, Asma Smahi, Alain Israël, Fabrice Agou, Musa M Mhlanga, Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti, Nature Communications, 2016, 7, pp.12629. ⟨10.1038/ncomms12629⟩.
• 2015
  Dubosclard V, Fontan E, Agou F, Use of fluorescence spectroscopy for quantitative investigations of ubiquitin interactions with the ubiquitin-binding domains of NEMO, Methods Mol. Biol. 2015;1280:321-37.
• 2015
  Agou F, Véron M, In vivo protein cross-linking, Methods Mol. Biol. 2015;1278:391-405.
• 2014
  Tarantino N, Tinevez JY, Crowell EF, Boisson B, Henriques R, Mhlanga M, Agou F, Israël A, Laplantine E, , TNF and IL-1 exhibit distinct ubiquitin requirements for inducing NEMO-IKK supramolecular structures., J Cell Biol 2014 Jan; 204(2): 231-45.
• 2011
  Chiaravalli J, Fontan E, Fsihi H, Coic YM, Baleux F, Véron M, Agou F, Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO, Biochem. Pharmacol. 2011 Nov;82(9):1163-74.
• 2009
  Grubisha O, Kaminska M, Duquerroy S, Fontan E, Cordier F, Haouz A, Raynal B, Chiaravalli J, Delepierre M, Israël A, Véron M, Agou F, DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding, J. Mol. Biol. 2010 Jan;395(1):89-104.
• 2008
  Cordier F, Grubisha O, Traincard F, Véron M, Delepierre M, Agou F, The zinc finger of NEMO is a functional ubiquitin-binding domain, J. Biol. Chem. 2009 Jan;284(5):2902-7.
• 2008
  Cordier F, Vinolo E, Véron M, Delepierre M, Agou F, Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation, J. Mol. Biol. 2008 Apr;377(5):1419-32.
• 2007
  Wyler E, Kaminska M, Coïc YM, Baleux F, Véron M, Agou F, Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO, Protein Sci. 2007 Sep;16(9):2013-22.
• 2007
  Fontan E, Traincard F, Levy SG, Yamaoka S, Véron M, Agou F, NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex, FEBS J. 2007 May;274(10):2540-51.
• 2004
  Agou F, Traincard F, Vinolo E, Courtois G, Yamaoka S, Israël A, Véron M, The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains, J. Biol. Chem. 2004 Jul;279(27):27861-9.
• 2004
  Agou F, Ye F, Véron M, In vivo protein cross-linking, Methods Mol. Biol. 2004;261:427-42.